Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), has today announced the publication...
AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced the...
AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced the...
Focalis Bio, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced...
AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced the...
Focalis Bio, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced...